Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma

  • Stefan Hohaus
  • , Manuela Giachelia
  • , Giuseppina Massini
  • , Barbara Vannata
  • , Marianna Criscuolo
  • , Maurizio Martini
  • , Francesco D'Alo'
  • , Maria Teresa Voso
  • , Luigi Maria Larocca
  • , Giuseppe Leone

Risultato della ricerca: Contributo in rivistaArticolo

29 Citazioni (Scopus)

Abstract

We studied plasma levels of IL-10 and five single nucleotide polymorphisms in the interleukin-10 (IL-10) gene promoter in patients with Hodgkin lymphoma (HL) to address potential genotype-phenotype correlations. Patients with elevated IL-10 levels were more likely to have advanced stage disease and inferior event-free survival. Homozygous carriers of the variant alleles at position -592 (AA) and -1082 (GG) of the IL-10 promoter had higher IL-10 plasma levels, independent of male gender and advanced stage of disease which also determined increased IL-10 production. This analysis indicates that the genetic background can modulate plasma levels of IL-10, and ultimately prognosis in HL.
Lingua originaleInglese
pagine (da-a)1352-1356
Numero di pagine5
RivistaLeukemia Research
Volume33
DOI
Stato di pubblicazionePubblicato - 2009

Keywords

  • Adult
  • DNA, Neoplasm
  • Epstein-Barr Virus Infections
  • Female
  • Gene Amplification
  • Genetic Variation
  • Herpesvirus 4, Human
  • Hodgkin Disease
  • Homozygote
  • Humans
  • Interleukin-10
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Polymorphism, Genetic
  • Polymorphism, Single Nucleotide
  • Prognosis
  • Promoter Regions, Genetic

Fingerprint

Entra nei temi di ricerca di 'Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma'. Insieme formano una fingerprint unica.

Cita questo